Casdin Partners Master Fund, L.P.

CIK 1534265 · last filed 2025-12-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$45.69M
Companies
5
Total Filings
15
Lifetime Open-Market Net
$11.92M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

BLFS price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
WALKER HOUSE
87 MARY STREET
GEORGE TOWN
Phone
(212) 300-5575
State of Incorporation
Cayman Islands
Related Filers
Casdin Capital, LLC — 76 joint filings, latest 2026-06-08
Casdin Partners GP, LLC — 74 joint filings, latest 2026-06-08
Eli Casdin — 67 joint filings, latest 2026-06-08
CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC — 29 joint filings, latest 2025-12-04
Casdin Private Growth Equity Fund, L.P. — 29 joint filings, latest 2025-12-04
Casdin Private Growth Equity Fund II GP, LLC — 28 joint filings, latest 2025-12-04
Casdin Private Growth Equity Fund II, L.P. — 28 joint filings, latest 2025-12-04
Casdin Amplify Fund, LP — 9 joint filings, latest 2025-03-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LAB Director 75,001,062 $0.61 $45.69M $1.88M 2 2025-12-04
BIOLIFE SOLUTIONS INC (BLFS) Delisted 10%+ Owner 14,664,330 $38.61 $566.19M -$21.41M 2 2025-10-17
2seventy bio, Inc. (TSVT) Delisted Director 2,016,600 $5.00 $10.08M $204.0K 1 2024-03-28
Verve Therapeutics, Inc. (VERV) Delisted 10%+ Owner 2,417,596 $11.13 $26.91M $20.90M 1 2021-06-22
Decibel Therapeutics, Inc. (DBTX) Delisted 10%+ Owner 1,121,421 $4.91 $5.51M $10.35M 1 2021-02-19

Holdings By Holder

Who holds the shares on record: the insider directly, and each trust, LLC, partnership or family member reported as an indirect holder on the latest Form 4 that lists them. Holder names come from the filing's footnotes. Rows under No longer reported appeared on earlier filings but not the latest one, usually because the holder was emptied or folded into another; they are not counted in the total.
Symbol Holder Shares Share of Total Reported
LAB Direct 2,901,062 3.9% 2025-12-04
Casdin Private Growth Equity Fund, L.P.
See footnote
72,100,000 96.1% 2025-12-04
Total 75,001,062
BLFS Direct 8,707,165 59.4% 2024-05-02
Footonote 5,957,165 40.6% 2025-10-17
Total 14,664,330
No longer reported
See footnote 0 — last 2024-05-02
TSVT Direct 16,600 0.8% 2024-03-28
Casdin Partners Master Fund, L.P.
See footnote.
2,000,000 99.2% 2024-03-28
Total 2,016,600
DBTX Casdin Partners Master Fund, L.P.
See footnote
1,121,421 100.0% 2021-02-19
Total 1,121,421

Recent Filings · Page 2 of 2

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2025-06-10 BIOLIFE SOLUTIONS INC (BLFS) Delisted Notice (144)
10% Owner · Planned Jun 10, 2025
Sold: listed on the Aug 11, 2025 notice
−1,000,000 -$23.91M EDGAR
2024-05-02 BIOLIFE SOLUTIONS INC (BLFS) Delisted Other (J) — $0 EDGAR
2024-03-28 2seventy bio, Inc. (TSVT) Delisted Buy (P) +40,000 $204.0K EDGAR
2021-06-22 Verve Therapeutics, Inc. (VERV) Delisted Mixed +2,417,596 $20.90M EDGAR
2021-02-19 Decibel Therapeutics, Inc. (DBTX) Delisted Mixed +1,121,421 $10.35M EDGAR
Showing 11–15 of 15
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).

Sales Reported Only on Form 144

5 sales · $60.02M
Each Form 144 lists the seller's sales of the company's stock in the 3 months before it. These are the sales on this filer's notices that no Form 4 on file shows, which is the usual case once someone is no longer an officer or director, or for an affiliate who never files Form 4s. Each sale is listed once, with the first notice that reported it.
Sold Symbol Shares Proceeds Avg Price Listed On
2026-05-20 BLFS 250,000 $5.92M $23.70 2026-05-21
2026-05-19 BLFS 300,000 $6.79M $22.65 2026-05-20
2025-08-15 BLFS 500,000 $12.20M $24.40 2025-10-15
2025-08-11 BLFS 500,000 $11.30M $22.60 2025-08-15
2025-06-10 BLFS 1,000,000 $23.80M $23.80 2025-08-11